Predictors of long-term survival among patients with brain metastases.
作者信息
Lamba Nayan, Catalano Paul J, Bi Wenya Linda, Wen Patrick Y, Haas-Kogan Daphne A, Cagney Daniel N, Aizer Ayal A
机构信息
Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Department of Biostatistics, Harvard T.H. Chan School of Public Health and Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
出版信息
Neuro Oncol. 2022 Mar 12;24(3):494-496. doi: 10.1093/neuonc/noab285.
Abstract
摘要
相似文献
1
Predictors of long-term survival among patients with brain metastases.脑转移瘤患者长期生存的预测因素。
Neuro Oncol. 2022 Mar 12;24(3):494-496. doi: 10.1093/neuonc/noab285.
2
Brain metastases from colorectal carcinoma. The long term survivors.
Cancer. 1996 Aug 15;78(4):711-6. doi: 10.1002/(SICI)1097-0142(19960815)78:4<711::AID-CNCR3>3.0.CO;2-H.
3
Early imaging radioresponsiveness of melanoma brain metastases as a predictor of patient prognosis.早期成像对黑色素瘤脑转移灶的放射反应性可作为预测患者预后的指标。
J Neurosurg. 2018 Aug;129(2):354-365. doi: 10.3171/2017.1.JNS162075. Epub 2017 Aug 25.
4
Prognostic factors and long-term survival in surgically treated brain metastases from non-small cell lung cancer.非小细胞肺癌脑转移瘤手术治疗后的预后因素及长期生存情况
Clin Neurol Neurosurg. 2016 Mar;142:72-80. doi: 10.1016/j.clineuro.2016.01.011. Epub 2016 Jan 14.
5
Natural history, clinical course and predictors of interval time from initial diagnosis to development of subsequent NSCLC brain metastases.从初始诊断到随后 NSCLC 脑转移发展的时间间隔的自然史、临床过程和预测因素。
J Neurooncol. 2019 May;143(1):145-155. doi: 10.1007/s11060-019-03149-4. Epub 2019 Mar 14.
6
[Analysis of Survival Predictors in Patients with Lung Cancer and Brain Metastases].[肺癌合并脑转移患者生存预测因素分析]
Zhongguo Fei Ai Za Zhi. 2015 Jul;18(7):436-42. doi: 10.3779/j.issn.1009-3419.2015.07.08.
7
Predictors of survival in patients with brain metastases from gastric cancer.胃癌脑转移患者的生存预测因素。
Neoplasma. 2017;64(1):136-139. doi: 10.4149/neo_2017_117.
8
Brain Metastases From Differentiated Thyroid Carcinoma: A Retrospective Study of 22 Patients.分化型甲状腺癌脑转移回顾性研究：22 例患者分析
Front Endocrinol (Lausanne). 2021 Sep 16;12:730025. doi: 10.3389/fendo.2021.730025. eCollection 2021.
9
Prognostic factors in patients treated with surgery for brain metastases: A single-center retrospective analysis of 125 patients.脑转移瘤患者手术治疗的预后因素：单中心 125 例回顾性分析。
Int J Surg. 2017 Aug;44:204-209. doi: 10.1016/j.ijsu.2017.05.033. Epub 2017 May 17.
10
Brain Metastases of Non-Small Cell Lung Cancer: Prognostic Factors in Patients with Surgical Resection.非小细胞肺癌脑转移：手术切除患者的预后因素
J Neurol Surg A Cent Eur Neurosurg. 2018 Mar;79(2):101-107. doi: 10.1055/s-0037-1601874. Epub 2017 Jun 6.
引用本文的文献
1
Unlocking the Role of Metabolic Pathways in Brain Metastatic Disease.揭示代谢途径在脑转移性疾病中的作用
Cells. 2025 May 13;14(10):707. doi: 10.3390/cells14100707.
2
Survival and quality of life after first-time diagnosis of brain metastases: a multicenter, prospective, observational study.首次诊断为脑转移瘤后的生存情况及生活质量：一项多中心、前瞻性、观察性研究。
Lancet Reg Health Eur. 2024 Dec 19;49:101181. doi: 10.1016/j.lanepe.2024.101181. eCollection 2025 Feb.
3
Predictors of brain metastases in patients with oligometastatic solid tumours treated with stereotactic body radiation therapy.立体定向体部放射治疗的寡转移实体瘤患者脑转移的预测因素
J Neurooncol. 2025 Jan;171(1):65-73. doi: 10.1007/s11060-024-04834-9. Epub 2024 Oct 4.
4
Long-term survival in patients with brain metastases-clinical characterization of a rare scenario.脑转移瘤患者的长期生存——罕见情况的临床特征。
Strahlenther Onkol. 2024 Apr;200(4):335-345. doi: 10.1007/s00066-023-02123-4. Epub 2023 Aug 30.
5
Heterogeneity in intracranial relapses after complete resection of lung adenocarcinoma: Distinct features of brain-only relapse versus synchronous extracranial relapse.肺癌完全切除术后颅内复发的异质性：单纯脑复发与同步颅外复发的不同特征。
Cancer Med. 2023 Jun;12(11):12495-12503. doi: 10.1002/cam4.5961. Epub 2023 Apr 16.
本文引用的文献
1
Epidemiology of brain metastases and leptomeningeal disease.脑转移瘤和软脑膜疾病的流行病学。
Neuro Oncol. 2021 Sep 1;23(9):1447-1456. doi: 10.1093/neuonc/noab101.
2
Population-based estimates of survival among elderly patients with brain metastases.基于人群的脑转移老年患者生存率估计。
Neuro Oncol. 2021 Apr 12;23(4):661-676. doi: 10.1093/neuonc/noaa233.
3
Neurosurgical Resection and Stereotactic Radiation Versus Stereotactic Radiation Alone in Patients with a Single or Solitary Brain Metastasis.单发或孤立性脑转移瘤患者的神经外科手术切除与立体定向放射治疗对比单纯立体定向放射治疗
World Neurosurg. 2019 Feb;122:e1557-e1561. doi: 10.1016/j.wneu.2018.11.100. Epub 2018 Nov 22.
4
Estimating Survival in Melanoma Patients With Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA).评估伴有脑转移的黑色素瘤患者的生存率：使用分子标志物的黑色素瘤分级预后评估（Melanoma-molGPA）的更新
Int J Radiat Oncol Biol Phys. 2017 Nov 15;99(4):812-816. doi: 10.1016/j.ijrobp.2017.06.2454.
5
Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study.初诊系统性恶性肿瘤患者脑转移的发生率和预后：一项基于人群的研究。
Neuro Oncol. 2017 Oct 19;19(11):1511-1521. doi: 10.1093/neuonc/nox077.
6
Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA).肺癌伴脑转移患者生存预测：基于分子标志物的肺癌预后分级评估（Lung-molGPA）的更新。
JAMA Oncol. 2017 Jun 1;3(6):827-831. doi: 10.1001/jamaoncol.2016.3834.
Zotero 插件